UnitedHealth Group's quarterly results have significantly exceeded analyst forecasts, leading the company to raise its full-year profit guidance substantially. This move is set to reinforce Wall Street's confidence in the company's financial turnaround.

UnitedHealth (UNH) shares rose 6% on Thursday.

The earnings report comes just over a year since Chief Executive Stephen Hemsley reassumed leadership of the company. Hemsley returned to the CEO role pledging major reforms after the company's financial performance deteriorated sharply a year ago.

Key Q2 Profit Figures

For the second quarter of 2026, UnitedHealth reported net income of $5.48 billion, or $6.04 per share. This compares to net income of $3.41 billion, or $3.74 per share, in the year-ago period.

Bolstered by the strong performance, the company raised its full-year adjusted earnings per share guidance to a range of $19.50 to $20.00. The previous lower end of the guidance was only $18.25. The consensus analyst estimate compiled by FactSet was $18.49.

Chief Financial Officer Wayne DeVeydt stated in an interview, "We have essentially reset the full-year performance benchmark." He noted that while the company was cautious with its outlook in the first quarter, the positive operational trends observed at that time are now judged to be sustainable.

Second-quarter adjusted earnings per share reached $6.38, far surpassing the FactSet analyst consensus estimate of $4.91.

Hemsley, who previously served as CEO for a long period before remaining as chairman, returned to the top executive position as the company faced operational pressures. Under his leadership, UnitedHealth has implemented several reforms: replacing a large number of senior executives, reducing the size of the Optum physician network, and strategically scaling back its core Medicare Advantage enrollment after years of aggressive expansion in the health insurance sector.

Medical Loss Ratio

The medical loss ratio, a closely watched metric representing the percentage of premium income spent on medical care, was 86.7% for the quarter. This was better than the analyst estimate of 88.4%.

The company attributed the improvement to optimized insurance product designs, premium rate increases, and more refined management of medical expenses.

DeVeydt explained that product rule adjustments included shifting from fixed copayments to coinsurance, where enrollees pay a percentage of medical costs. The company is also using AI tools to screen for improper claims, countering healthcare providers' use of AI to generate bills en masse. He said, "We are leveraging artificial intelligence to identify various anomalous reimbursement claims."

Management stated that approximately $1.5 billion in AI investments this year will effectively reduce costs and improve operational efficiency. UnitedHealth recently announced a partnership with Anthropic.

Cost Trends by Business Segment

Medicare Business: Cost growth was lower than expected. The company had previously set aside additional profit buffers for potential risks such as tariffs, but these risks did not materialize.

Medicaid Business: Costs were in line with, or slightly better than, expectations. While states have increased reimbursement rates, the company still expects this segment to post a small loss for the full year.

Commercial Group Health Insurance Business: Medical expense growth exceeded 11%, higher than previously anticipated. The primary increase stemmed from high costs associated with the federal independent dispute resolution process, which was established to prevent surprise medical bills. UnitedHealth and other insurers have sued healthcare providers, alleging that a flood of non-compliant bills into the arbitration process has significantly driven up operational costs.

Revenue Data

Total revenue for the second quarter was $112.0 billion, compared to $111.6 billion in the same period last year.